present and seek ratification approval from the shareholders’ meeting. The Company will hold the Board of Directors’ meeting on February 26, 2019 to consider including this matter as an agenda to ratify the
and facilities in the industrial sectors on an one stop service basis. No. WHAUP-CS021/2017 In consideration of the said matter, Mr. Somyos Anantaprayoon*, Ms. Jareeporn Jarukornsakul, Mr. David Richard
application for a license and the granting of a license to provide services as a securities registrar, which is subject to other specific rules governing such matter as prescribed by other Notifications. Clause
application for a license and the granting of a license to provide services as a securities registrar, which is subject to other specific rules governing such matter as prescribed by other Notifications. Clause
from the date on which such matter occurs and it shall be deemed that the securities company is given an exemption by the Office from appointment of independent director during such period. Clause 3. Any
from the date on which such matter occurs and it shall be deemed that the securities company is given an exemption by the Office from appointment of independent director during such period. Clause 3. Any
independent director within 90 days from the date on which such matter occurs and it shall be deemed that the securities company is given an exemption by the Office from appointment of independent director
application for a license and the granting of a license to provide services as a securities registrar, which is subject to other specific rules governing such matter as prescribed by other Notifications. Clause
matter to the Securities and Exchange Commission for consideration and making order in relation to the application for the derivatives exchange license within one hundred and twenty days from the date on
, diversified and steady cash flows, growing with a combined EBITDA of 18% YoY and 44% LTM 2Q19. The Integrated Oxides & Derivatives segment was negatively impacted by the extended shutdown into 2Q19 following